Your browser doesn't support javascript.
loading
Association Between Helicobacter pylori and Steatosis Severity on Transient Elastography.
Fialho, Andre; Fialho, Andrea; Ribeiro, Bruno; Malespin, Miguel; De Melo, Silvio; Schey, Ron; Ghali, Peter.
Afiliação
  • Fialho A; Internal Medicine: Gastroenterology, South Central Regional Medical Center, Laurel, USA.
  • Fialho A; Internal Medicine: Gastroenterology, South Central Regional Medical Center, Laurel, USA.
  • Ribeiro B; Gastroenterology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
  • Malespin M; Gastroenterology and Hepatology, Tampa General Hospital, Tampa, USA.
  • De Melo S; Gastroenterology, Orlando Veterans Affairs Medical Center, Orlando, USA.
  • Schey R; Gastroenterology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
  • Ghali P; Gastroenterology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
Cureus ; 15(1): e34042, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36699110
Background A possible association between Helicobacter pylori (HP) infection and liver diseases including steatosis is suspected. There is a lack of studies evaluating the association of HP and liver steatosis severity using transient elastography. Aim The aim of this study was to evaluate the frequency and risk factors for liver steatosis measured by transient elastography in patients with or without HP. Methods A total of 484 patients tested for liver steatosis and fibrosis using transient elastography from January 2017 to June 2018 were evaluated. Ninety-one patients who were also tested for H. pylori infection were included in the study. Transient elastography findings were compared between HP-positive patients and HP-negative patients. Demographic, clinical, and laboratory variables and the presence and severity of liver fibrosis and steatosis were analyzed. Results Patients with HP had a higher frequency of steatosis on transient elastography (86.8% vs. 60.7%, p =0.009). Patients with HP had increased steatosis severity compared to HP-negative patients (mild steatosis 15.8% vs. 7.1%, p=0.037; moderate to severe steatosis 71.1% vs. 53.6%, p=0.015, respectively). In the stepwise multivariate logistic regression analysis, HP infection remained an independent risk factor for steatosis (odds ratio: 4.36, 95% confidence interval: 1.09-14.78; p=0.037). Conclusion Patients with HP had an increased steatosis frequency, and patients with liver steatosis may warrant HP evaluation and treatment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos